Wealthspire Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1646247
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,390,968
-$2,335,635 QoQ
Shares Held
7,042
-19.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#407
of 1,327 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthspire Advisors, LLC holds $11,785,631 across 19 Biotechnology names. REGN ranks #1 (37.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
7,042 | $4,390,968 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
721,788 | $3,349,096 | |
| 3 | OCUL |
Ocular Therapeutix, Inc
|
162,960 | $1,600,267 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,138 | $565,278 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
3,540 | $307,803 | |
| 6 | MRNA |
Moderna, Inc.
|
3,953 | $276,828 | |
| 7 | RNXT |
RenovoRx, Inc.
|
252,525 | $247,474 | |
| 8 | MREO |
Mereo BioPharma Group plc
|
765,000 | $243,270 |
All Filings in REGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,390,968 | 7,042 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,726,603 | 8,706 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,503,174 | 3,243 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,677,813 | 2,984 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,221,925 | 6,137 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,930,050 | 9,350 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,002,582 | 5,619 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $8,527,658 | 8,112 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $492,933 | 469 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $465,845 | 484 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $472,520 | 538 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $376,915 | 458 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $317,594 | 442 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $203,774 | 248 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $207,067 | 287 | Shares | Sole | 2023-02-14 | |
| 2021-03-31 | $339,714 | 718 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,683,638 | 3,485 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,604,889 | 2,867 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,502,996 | 2,410 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,025,409 | 2,100 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||